Novartis AG (ADR) news

   Watch this stock
Showing stories 11 - 20 of about 51   

Articles published

NVS 74.15 -0.86 (-1.15%)
price chart
Latest Merger & Acquisition Activities - Actavis (NYSE:ACT), DDR Corp (NYSE ...
Techsonian (press release) - May 17, 2013
Despite hitting new high on Thursday, Actavis Inc (NYSE:ACT) edged lower after a spokesman for Novartis said the Swiss drugmaker has no plans to bid for the U.S.
US Court Finds Bayer AG�s Yaz Contraceptive Patent Claims Invalid; Actavis Inc, Drug Unit of Novartis AG And Lupin Ltd Involved in Rulling-Reuters
Reuters Key Development - Apr 16, 2013
UK Cost Body Rejects Novartis AG's Breast Cancer Drug-Reuters
Reuters Key Development - Mar 20, 2013
Novartis AG's Alcon Unit Gets EU Approval For Jetrea Eye Drug-Reuters
Reuters Key Development - Mar 18, 2013
Orexo AB Announces Agreement with Novartis AG on OX17 for GERD Terminated
Reuters Key Development - Feb 25, 2013
UK Cost Agency Says No To Novartis AG's Blood Cancer Drug Jakavi-Reuters
Reuters Key Development - Feb 13, 2013
Novartis AG Recalls Cough Syrups Due To Cap Seal Defect-Reuters
Reuters Key Development - Jan 31, 2013
EU Regulator Charges Johnson & Johnson, Novartis AG Over Dutch Painkiller Delay-Reuters
Reuters Key Development - Jan 31, 2013
Novartis AG's CEO Tempers Talk Of Roche Holding AG Stake Sale-Reuters
Reuters Key Development - Jan 25, 2013
Novartis AG Announces FDA Approval For Exjade In Patients With Genetic Blood Disorder-Reuters
Reuters Key Development - Jan 23, 2013

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.
To see all exchange delays, please see disclaimer.

©2013 Google - Google Home - Blog - Help - Report a Problem - Privacy Policy - Terms of Service